ADAR1 Capital Management, LLC
Endast köp på öppna marknaden. Namn matchas mot en normaliserad nyckel, så namnesar kan slås ihop.
Köpposter
69
69 fortfarande öppna
Bolag
4
Investerat
13.4 mn SEK
till köpkurs
Snittavkastning
+20,0%
100% positiv
Köp
CAR = 40-dagars marknads- och peerjusterad avkastning| Datum | Bolag | Befattning | Flaggor | Volym | Pris | Värde | CAR 40d |
|---|
Positionsregister
FIFO matchat mot rapporterade avyttringar| Öppnad | Bolag | Status | Antal | Kvarvarande | Ingång | Realiserad | Orealiserad | Dagar |
|---|---|---|---|---|---|---|---|---|
| 2026-08-24 | TENAX THERAPEUTICS, INC. | öppen | 107 k | 107 k | 1,75 | – | +6,0% | 9 |
| 2026-08-24 | TENAX THERAPEUTICS, INC. | öppen | 107 k | 107 k | 1,75 | – | +6,0% | 9 |
| 2026-08-24 | TENAX THERAPEUTICS, INC. | öppen | 107 k | 107 k | 1,75 | – | +6,0% | 9 |
| 2026-08-21 | TENAX THERAPEUTICS, INC. | öppen | 716 k | 716 k | 1,77 | – | +5,2% | 12 |
| 2026-08-21 | TENAX THERAPEUTICS, INC. | öppen | 716 k | 716 k | 1,77 | – | +5,2% | 12 |
| 2026-08-21 | TENAX THERAPEUTICS, INC. | öppen | 716 k | 716 k | 1,77 | – | +5,2% | 12 |
| 2026-08-20 | TENAX THERAPEUTICS, INC. | öppen | 202 k | 202 k | 1,78 | – | +4,6% | 13 |
| 2026-08-20 | TENAX THERAPEUTICS, INC. | öppen | 202 k | 202 k | 1,78 | – | +4,6% | 13 |
| 2026-08-20 | TENAX THERAPEUTICS, INC. | öppen | 202 k | 202 k | 1,78 | – | +4,6% | 13 |
| 2026-07-31 | NextCure, Inc. | öppen | 8 k | 8 k | 4,80 | – | +27,3% | 33 |
| 2026-07-31 | NextCure, Inc. | öppen | 3 k | 3 k | 4,98 | – | +22,8% | 33 |
| 2026-07-31 | NextCure, Inc. | öppen | 25 k | 25 k | 4,98 | – | +22,6% | 33 |
| 2026-07-31 | NextCure, Inc. | öppen | 8 k | 8 k | 4,80 | – | +27,3% | 33 |
| 2026-07-31 | NextCure, Inc. | öppen | 3 k | 3 k | 4,98 | – | +22,8% | 33 |
| 2026-07-31 | NextCure, Inc. | öppen | 25 k | 25 k | 4,98 | – | +22,6% | 33 |
| 2026-07-31 | NextCure, Inc. | öppen | 3 k | 3 k | 4,98 | – | +22,8% | 33 |
| 2026-07-31 | NextCure, Inc. | öppen | 25 k | 25 k | 4,98 | – | +22,6% | 33 |
| 2026-07-31 | NextCure, Inc. | öppen | 8 k | 8 k | 4,80 | – | +27,3% | 33 |
| 2026-07-30 | NextCure, Inc. | öppen | 20 k | 20 k | 5,00 | – | +22,2% | 34 |
| 2026-07-30 | NextCure, Inc. | öppen | 100 k | 100 k | 4,90 | – | +24,7% | 34 |
| 2026-07-30 | NextCure, Inc. | öppen | 78 k | 78 k | 4,96 | – | +23,3% | 34 |
| 2026-07-30 | NextCure, Inc. | öppen | 25 k | 25 k | 4,81 | – | +26,9% | 34 |
| 2026-07-30 | NextCure, Inc. | öppen | 20 k | 20 k | 5,00 | – | +22,2% | 34 |
| 2026-07-30 | NextCure, Inc. | öppen | 20 k | 20 k | 5,00 | – | +22,2% | 34 |
| 2026-07-30 | NextCure, Inc. | öppen | 50 k | 50 k | 4,97 | – | +22,8% | 34 |
| 2026-07-30 | NextCure, Inc. | öppen | 20 k | 20 k | 5,00 | – | +22,2% | 34 |
| 2026-07-30 | NextCure, Inc. | öppen | 25 k | 25 k | 4,81 | – | +26,9% | 34 |
| 2026-07-30 | NextCure, Inc. | öppen | 100 k | 100 k | 4,90 | – | +24,7% | 34 |
| 2026-07-30 | NextCure, Inc. | öppen | 78 k | 78 k | 4,96 | – | +23,3% | 34 |
| 2026-07-30 | NextCure, Inc. | öppen | 78 k | 78 k | 4,96 | – | +23,3% | 34 |
| 2026-07-30 | NextCure, Inc. | öppen | 100 k | 100 k | 4,90 | – | +24,7% | 34 |
| 2026-07-30 | NextCure, Inc. | öppen | 50 k | 50 k | 4,97 | – | +22,8% | 34 |
| 2026-07-30 | NextCure, Inc. | öppen | 50 k | 50 k | 4,97 | – | +22,8% | 34 |
| 2026-07-30 | NextCure, Inc. | öppen | 20 k | 20 k | 5,00 | – | +22,2% | 34 |
| 2026-07-30 | NextCure, Inc. | öppen | 20 k | 20 k | 5,00 | – | +22,2% | 34 |
| 2026-07-30 | NextCure, Inc. | öppen | 25 k | 25 k | 4,81 | – | +26,9% | 34 |
| 2026-07-29 | NextCure, Inc. | öppen | 2 k | 2 k | 5,00 | – | +22,2% | 35 |
| 2026-07-29 | NextCure, Inc. | öppen | 2 k | 2 k | 5,00 | – | +22,2% | 35 |
| 2026-07-29 | NextCure, Inc. | öppen | 2 k | 2 k | 5,00 | – | +22,2% | 35 |
| 2026-07-29 | NextCure, Inc. | öppen | 2 k | 2 k | 5,00 | – | +22,2% | 35 |
| 2026-07-29 | NextCure, Inc. | öppen | 2 k | 2 k | 5,00 | – | +22,2% | 35 |
| 2026-07-29 | NextCure, Inc. | öppen | 2 k | 2 k | 5,00 | – | +22,2% | 35 |
| 2026-07-28 | NextCure, Inc. | öppen | 6 k | 6 k | 4,95 | – | +23,4% | 36 |
| 2026-07-28 | NextCure, Inc. | öppen | 6 k | 6 k | 4,95 | – | +23,4% | 36 |
| 2026-07-28 | NextCure, Inc. | öppen | 6 k | 6 k | 4,95 | – | +23,4% | 36 |
| 2026-07-27 | NextCure, Inc. | öppen | 8 k | 8 k | 5,00 | – | +22,2% | 37 |
| 2026-07-27 | NextCure, Inc. | öppen | 8 k | 8 k | 5,00 | – | +22,2% | 37 |
| 2026-07-27 | NextCure, Inc. | öppen | 8 k | 8 k | 5,00 | – | +22,2% | 37 |
| 2026-07-15 | InMed Pharmaceuticals Inc.⚠ | öppen | 1 k | 1 k | 1,56 | – | – | 49 |
| 2026-07-15 | InMed Pharmaceuticals Inc.⚠ | öppen | 1 k | 1 k | 1,56 | – | – | 49 |
| 2026-07-15 | InMed Pharmaceuticals Inc.⚠ | öppen | 1 k | 1 k | 1,56 | – | – | 49 |
| 2026-05-19 | InMed Pharmaceuticals Inc.⚠ | öppen | 200 k | 200 k | 1,50 | – | – | 106 |
| 2026-05-19 | InMed Pharmaceuticals Inc.⚠ | öppen | 200 k | 200 k | 1,56 | – | – | 106 |
| 2026-05-19 | InMed Pharmaceuticals Inc.⚠ | öppen | 200 k | 200 k | 1,50 | – | – | 106 |
| 2026-05-19 | InMed Pharmaceuticals Inc.⚠ | öppen | 69 k | 69 k | 1,60 | – | – | 106 |
| 2026-05-19 | InMed Pharmaceuticals Inc.⚠ | öppen | 69 k | 69 k | 1,60 | – | – | 106 |
| 2026-05-19 | InMed Pharmaceuticals Inc.⚠ | öppen | 200 k | 200 k | 1,56 | – | – | 106 |
| 2026-05-19 | InMed Pharmaceuticals Inc.⚠ | öppen | 200 k | 200 k | 1,50 | – | – | 106 |
| 2026-05-19 | InMed Pharmaceuticals Inc.⚠ | öppen | 69 k | 69 k | 1,60 | – | – | 106 |
| 2026-05-19 | InMed Pharmaceuticals Inc.⚠ | öppen | 200 k | 200 k | 1,56 | – | – | 106 |
| 2026-05-19 | Rallybio Corp⚠ | öppen | 10 k | 10 k | 13,98 | – | – | 106 |
| 2026-05-19 | Rallybio Corp⚠ | öppen | 10 k | 10 k | 13,98 | – | – | 106 |
| 2026-05-19 | Rallybio Corp⚠ | öppen | 200 | 200 | 13,80 | – | – | 106 |
| 2026-05-19 | Rallybio Corp⚠ | öppen | 200 | 200 | 13,80 | – | – | 106 |
| 2026-05-19 | Rallybio Corp⚠ | öppen | 10 k | 10 k | 13,98 | – | – | 106 |
| 2026-05-19 | Rallybio Corp⚠ | öppen | 200 | 200 | 13,80 | – | – | 106 |
| 2026-05-18 | Rallybio Corp⚠ | öppen | 6 k | 6 k | 13,98 | – | – | 107 |
| 2026-05-18 | Rallybio Corp⚠ | öppen | 6 k | 6 k | 13,98 | – | – | 107 |
| 2026-05-18 | Rallybio Corp⚠ | öppen | 6 k | 6 k | 13,98 | – | – | 107 |

